These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 8817154)

  • 1. Vitamin D deficiency and osteoporosis: the role of vitamin D deficiency and treatment with vitamin D and analogues in the prevention of osteoporosis-related fractures.
    Lips P
    Eur J Clin Invest; 1996 Jun; 26(6):436-42. PubMed ID: 8817154
    [No Abstract]   [Full Text] [Related]  

  • 2. Was it inappropriate to give patients with osteoporosis calcitriol instead of vitamin D?
    Vieth R
    J Am Geriatr Soc; 2008 Mar; 56(3):575-6; author reply 576-7. PubMed ID: 18315678
    [No Abstract]   [Full Text] [Related]  

  • 3. [Administration of vitamin D3 and its active metabolites in the prevention and treatment of osteoporosis].
    Lips P
    Ned Tijdschr Geneeskd; 1996 Jan; 140(2):65-8. PubMed ID: 8569923
    [No Abstract]   [Full Text] [Related]  

  • 4. Vitamin D therapy of osteoporosis: plain vitamin D therapy versus active vitamin D analog (D-hormone) therapy.
    Lau KH; Baylink DJ
    Calcif Tissue Int; 1999 Oct; 65(4):295-306. PubMed ID: 10485982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis.
    Avenell A; Gillespie WJ; Gillespie LD; O'Connell DL
    Cochrane Database Syst Rev; 2005 Jul; (3):CD000227. PubMed ID: 16034849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis.
    Gillespie WJ; Henry DA; O'Connell DL; Robertson J
    Cochrane Database Syst Rev; 2000; (2):CD000227. PubMed ID: 10796331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D and analogues in renal bone disease and implications for osteoporosis.
    Kanis JA; McCloskey EV; Beneton MN
    Osteoporos Int; 1997; 7 Suppl 3():S179-83. PubMed ID: 9536328
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention and therapy of osteoporosis: the roles of plain vitamin D and alfacalcidol.
    Ringe JD; Schacht E
    Rheumatol Int; 2004 Jul; 24(4):189-97. PubMed ID: 15232715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of glucocorticoid-induced osteoporosis with calcium, vitamin D and D-metabolites.
    Ringe JD
    Front Horm Res; 2002; 30():127-35. PubMed ID: 11892259
    [No Abstract]   [Full Text] [Related]  

  • 10. Vitamin D metabolism and its clinical application.
    Kanis JA
    J Bone Joint Surg Br; 1982; 64(5):542-60. PubMed ID: 6754741
    [No Abstract]   [Full Text] [Related]  

  • 11. Vitamin D and the D-hormones, alfacalcidol and calcitriol, as therapeutic agents for osteoporotic populations.
    Avioli LV
    Calcif Tissue Int; 1999 Oct; 65(4):292-4. PubMed ID: 10485981
    [No Abstract]   [Full Text] [Related]  

  • 12. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
    Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
    Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vitamin D and its active metabolites in the prevention and treatment of osteoporosis].
    Rivier E
    Rev Med Suisse Romande; 1998 Mar; 118(3):267-77. PubMed ID: 9594604
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of vitamin D and calcium supplementation in the prevention of osteoporotic fractures in the elderly.
    Compston JE
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):393-405. PubMed ID: 7586612
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies of osteoporosis in Japan.
    Fujita T
    Metabolism; 1990 Apr; 39(4 Suppl 1):39-42. PubMed ID: 2325570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis.
    Jones G; Hogan DB; Yendt E; Hanley DA
    CMAJ; 1996 Oct; 155(7):955-61. PubMed ID: 8837546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occult vitamin D deficiency in postmenopausal US women with acute hip fracture.
    LeBoff MS; Kohlmeier L; Hurwitz S; Franklin J; Wright J; Glowacki J
    JAMA; 1999 Apr; 281(16):1505-11. PubMed ID: 10227320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of vitamin D and its metabolites in the pathogenesis and therapy of osteoporosis].
    Scharla SH; Ziegler R
    Dtsch Med Wochenschr; 1994 Jun; 119(23):847-51. PubMed ID: 8005057
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevention and treatment of vitamin D deficiency in aged patients: a proven efficacy].
    Trivalle C; Sebag-Lanoë R; Guillemant S
    Rev Med Interne; 1999 Sep; 20(9):755-8. PubMed ID: 10522295
    [No Abstract]   [Full Text] [Related]  

  • 20. Rationale for active vitamin D and analogs in the treatment of osteoporosis.
    Nishii Y
    J Cell Biochem; 2003 Feb; 88(2):381-6. PubMed ID: 12520540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.